| pubmed-article:20630708 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C0599851 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C0019564 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C0002708 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C0679575 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:20630708 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:20630708 | pubmed:issue | 1-3 | lld:pubmed |
| pubmed-article:20630708 | pubmed:dateCreated | 2010-9-3 | lld:pubmed |
| pubmed-article:20630708 | pubmed:abstractText | The temporolimbic region has been implicated in the pathophysiology in schizophrenia. More specifically, significantly smaller hippocampal volumes but not amygdala volumes have been identified at onset in first-episode schizophrenia (FES) patients. However, volumetric differences (namely, in the hippocampus) exhibit an ambiguous relationship with long-term outcome. So, we examined the relationship between hippocampus and amygdala volumes and early remission status. | lld:pubmed |
| pubmed-article:20630708 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20630708 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20630708 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20630708 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20630708 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20630708 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20630708 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20630708 | pubmed:issn | 1573-2509 | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:JooberRidhaR | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:MallaAshok... | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:PruessnerMari... | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:LepageMartinM | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:BenoitAudreyA | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:FathalliFerid... | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:PruessnerJens... | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:CzechowskaYvo... | lld:pubmed |
| pubmed-article:20630708 | pubmed:author | pubmed-author:BodnarMichael... | lld:pubmed |
| pubmed-article:20630708 | pubmed:copyrightInfo | (c) 2010 Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:20630708 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20630708 | pubmed:volume | 122 | lld:pubmed |
| pubmed-article:20630708 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20630708 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20630708 | pubmed:pagination | 72-80 | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:meshHeading | pubmed-meshheading:20630708... | lld:pubmed |
| pubmed-article:20630708 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20630708 | pubmed:articleTitle | Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala. | lld:pubmed |
| pubmed-article:20630708 | pubmed:affiliation | Brain Imaging Group, Douglas Mental Health University Institute, Montreal, Canada. michael.bodnar@douglas.mcgill.ca | lld:pubmed |
| pubmed-article:20630708 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20630708 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
